Preterm Birth and PROM Testing

Preterm Birth and PROM Testing Market Outlook over 2021-2030 Preterm Birth and PROM Testing Market Size, Share and Growth Analysis, Trends, Regional Outlook, and Forecast 2021 - 2030

Share This Article

As per the experts, the preterm birth and PROM testing market is predicted to record a growth rate of 3.2% from 2021-2030 and is projected to reach US$ 2.1 billion by 2030.

The study provides the overall revenue of the global preterm birth and PROM testing market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global preterm birth and PROM testing market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the preterm birth and PROM testing industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

Crucial factors accountable for market growth are:

  • Rising cases of preterm birth across the world
  • Growing penetration of diagnostic labs and healthcare centers
  • Rising awareness regarding the preterm birth and PROM testing availability
  • Point of Care test is gaining traction
  • Technological advancements in the PROM testing tools
  • Growing penetration of online consultation of doctors or telemedicine

We customize your report according to your research need. REQUEST SAMPLE OR CUSTOMIZED COPY OF THIS REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1281

Report Highlights

  • Ultrasound segment led the global preterm birth and PROM testing market with 32% revenue share in 2020. This is attributed to the fact that ultrasound is the most common, reliable, and painless way of PROM testing.
  • By end user, diagnostic laboratories segment held 45% revenue share in the global preterm birth and PROM testing market in 2020 owing to the higher demand and the growing penetration in the developed markets.
  • North America dominated the global market in 2020 and projected to augment the market in the coming years due to the growing cases of preterm birth rate in U.S. According to CDC (Centers for Disease Control and Prevention), 10% of the babies born in 2019 in US were born preterm. Around 17% of the preterm babies die due to low birth weight.
  • Asia Pacific is fastest growing market owing to the rising awareness regarding preterm birth. According to the WHO, over 60% of the preterm birth cases occurs in Africa and South Asia. The rapid development of healthcare facilities in Asia is a factor that is anticipated to be the driving force of the market.

Report Coverage:

Report Highlights Details
Market Size USD 2.1 Billion by 2030
Growth Rate CAGR of 3.2% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Test Type, End User
Regional Scope North America, APAC, Europe, Latin America, MEAN, Rest of the World
Segments Covered Abbott, Qiagen N.V., Biosynex, Hologic, Cooper Surgical, Sera Prognostics, Medixbiochemica, IQ Products, NX Prenatal, Inc., Clinical Innovations, Inc.

Segments Covered in the Report

By Test Type

  • Ultrasound
  • Biochemical Markers
  • Pelvic Exam
  • Nitazine Test
  • Uterine Monitoring
  • Pooling
  • Ferning Test
  • Others

By End User

  • Diagnostic Laboratories
  • Hospitals
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Recent Developments

  • In April 2018, QIAGEN acquired approval from FDA for PartoSure, a new point of care test product. This new test was launched to identify women or patients having preterm labor symptoms.
  • The major players in the market are Abbott, Qiagen N.V., Biosynex, Hologic, Cooper Surgical, Sera Prognostics, Medixbiochemica, IQ Products, NX Prenatal, Inc., and Clinical Innovations, Inc..

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global preterm birth and PROM testing market are as follows:

  • Abbott
  • Qiagen N.V.
  • Biosynex
  • Hologic
  • Cooper Surgical
  • Sera Prognostics
  • Medixbiochemica
  • IQ Products
  • NX Prenatal, Inc.
  • Clinical Innovations, Inc.

Some of the key highlights of the report are:

  • Market Demand Outlook – The report offers refined forecasts on potential growth prospects for the market. Based on data derived after thorough research by a team of expert analysis, Precedence Research presents the most precise rate of growth for the market for the assessment period starting from 2021 – 2030.
  • Supply Chain Analysis – The purpose of the survey is to help companies identify potential scope for supply chain expansion. The study also presents analysis of unprecedented threats.
  • Competitive Landscape Analysis – Some of the leading companies operating in the preterm birth and PROM testing market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Why should you invest in this report?

If you are aiming to enter the global preterm birth and PROM testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for preterm birth and PROM testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Preterm Birth and PROM Testing Market, By Test

7.1. Preterm Birth and PROM Testing Market, by Test Type, 2021-2030

7.1.1. Ultrasound

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Biochemical Markers

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Pelvic Exam

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Nitazine Test

7.1.4.1. Market Revenue and Forecast (2017-2030)

7.1.5. Uterine Monitoring

7.1.5.1. Market Revenue and Forecast (2017-2030)

7.1.6. Pooling

7.1.6.1. Market Revenue and Forecast (2017-2030)

7.1.7. Ferning Test

7.1.7.1. Market Revenue and Forecast (2017-2030)

7.1.8. Others

7.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Preterm Birth and PROM Testing Market, By End User

8.1. Preterm Birth and PROM Testing Market, by End User, 2021-2030

8.1.1. Diagnostic Laboratories

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Hospitals

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Preterm Birth and PROM Testing Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Test (2017-2030)

9.1.2. Market Revenue and Forecast, by End User (2017-2030)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.1.3.2. Market Revenue and Forecast, by End User (2017-2030)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.1.4.2. Market Revenue and Forecast, by End User (2017-2030)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.2. Market Revenue and Forecast, by End User (2017-2030)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.3.2. Market Revenue and Forecast, by End User (2017-2030)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.4.2. Market Revenue and Forecast, by End User (2017-2030)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.5.2. Market Revenue and Forecast, by End User (2017-2030)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.6.2. Market Revenue and Forecast, by End User (2017-2030)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.2. Market Revenue and Forecast, by End User (2017-2030)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.3.2. Market Revenue and Forecast, by End User (2017-2030)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.4.2. Market Revenue and Forecast, by End User (2017-2030)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.5.2. Market Revenue and Forecast, by End User (2017-2030)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.6.2. Market Revenue and Forecast, by End User (2017-2030)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.2. Market Revenue and Forecast, by End User (2017-2030)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.3.2. Market Revenue and Forecast, by End User (2017-2030)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.4.2. Market Revenue and Forecast, by End User (2017-2030)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.5.2. Market Revenue and Forecast, by End User (2017-2030)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.6.2. Market Revenue and Forecast, by End User (2017-2030)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Test (2017-2030)

9.5.2. Market Revenue and Forecast, by End User (2017-2030)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.5.3.2. Market Revenue and Forecast, by End User (2017-2030)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.5.4.2. Market Revenue and Forecast, by End User (2017-2030)

Chapter 10. Company Profiles

10.1. Abbott

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. Qiagen N.V.

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Biosynex

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Hologic

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. Cooper Surgical

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Sera Prognostics

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Medixbiochemica

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. IQ Products

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. NX Prenatal, Inc.

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Clinical Innovations, Inc.

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1281

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →